185 related articles for article (PubMed ID: 27258646)
1. CACNA1H(M1549V) Mutant Calcium Channel Causes Autonomous Aldosterone Production in HAC15 Cells and Is Inhibited by Mibefradil.
Reimer EN; Walenda G; Seidel E; Scholl UI
Endocrinology; 2016 Aug; 157(8):3016-22. PubMed ID: 27258646
[TBL] [Abstract][Full Text] [Related]
2. Cellular Pathophysiology of Mutant Voltage-Dependent Ca2+ Channel CACNA1H in Primary Aldosteronism.
Gürtler F; Jordan K; Tegtmeier I; Herold J; Stindl J; Warth R; Bandulik S
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32785697
[TBL] [Abstract][Full Text] [Related]
3. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.
Scholl UI; Stölting G; Nelson-Williams C; Vichot AA; Choi M; Loring E; Prasad ML; Goh G; Carling T; Juhlin CC; Quack I; Rump LC; Thiel A; Lande M; Frazier BG; Rasoulpour M; Bowlin DL; Sethna CB; Trachtman H; Fahlke C; Lifton RP
Elife; 2015 Apr; 4():e06315. PubMed ID: 25907736
[TBL] [Abstract][Full Text] [Related]
4. Somatic
Nanba K; Blinder AR; Rege J; Hattangady NG; Else T; Liu CJ; Tomlins SA; Vats P; Kumar-Sinha C; Giordano TJ; Rainey WE
Hypertension; 2020 Mar; 75(3):645-649. PubMed ID: 31983310
[TBL] [Abstract][Full Text] [Related]
5. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Ca
Seidel E; Schewe J; Zhang J; Dinh HA; Forslund SK; Markó L; Hellmig N; Peters J; Muller DN; Lifton RP; Nottoli T; Stölting G; Scholl UI
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879608
[TBL] [Abstract][Full Text] [Related]
7. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
8. A Novel Somatic Mutation of
Tseng CS; Peng KY; Wang SM; Tsai YC; Huang KH; Lin WC; Hu YH; Wu VC; Chueh JS
Front Endocrinol (Lausanne); 2022; 13():816476. PubMed ID: 35757409
[TBL] [Abstract][Full Text] [Related]
9. CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism.
Daniil G; Fernandes-Rosa FL; Chemin J; Blesneac I; Beltrand J; Polak M; Jeunemaitre X; Boulkroun S; Amar L; Strom TM; Lory P; Zennaro MC
EBioMedicine; 2016 Nov; 13():225-236. PubMed ID: 27729216
[TBL] [Abstract][Full Text] [Related]
10. Role of membrane depolarization and T-type Ca2+ channels in angiotensin II and K+ stimulated aldosterone secretion.
Lotshaw DP
Mol Cell Endocrinol; 2001 Apr; 175(1-2):157-71. PubMed ID: 11325526
[TBL] [Abstract][Full Text] [Related]
11. Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.
Lenzini L; Caroccia B; Campos AG; Fassina A; Belloni AS; Seccia TM; Kuppusamy M; Ferraro S; Skander G; Bader M; Rainey WE; Rossi GP
J Clin Endocrinol Metab; 2014 Apr; 99(4):E674-82. PubMed ID: 24285684
[TBL] [Abstract][Full Text] [Related]
12. Ca
Dinh HA; Stölting G; Scholl UI
Handb Exp Pharmacol; 2023; 279():249-262. PubMed ID: 37311830
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Different Calcium Channel Blockers on Aldosterone-Producing Adenoma Cells.
Wang F; Ma X; Tong A; Zhang Y; Wen J; Li Y
Front Endocrinol (Lausanne); 2020; 11():260. PubMed ID: 32411097
[No Abstract] [Full Text] [Related]
14. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
Imagawa K; Okayama S; Takaoka M; Kawata H; Naya N; Nakajima T; Horii M; Uemura S; Saito Y
J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797
[TBL] [Abstract][Full Text] [Related]
16. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
[TBL] [Abstract][Full Text] [Related]
17. Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
Isaka T; Ikeda K; Takada Y; Inada Y; Tojo K; Tajima N
Eur J Pharmacol; 2009 Mar; 605(1-3):49-52. PubMed ID: 19168055
[TBL] [Abstract][Full Text] [Related]
18. Calneuron 1 Increased Ca
Kobuke K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Ohno H; Itcho K; Yoshii Y; Yoneda M; Hattori N
Hypertension; 2018 Jan; 71(1):125-133. PubMed ID: 29109191
[TBL] [Abstract][Full Text] [Related]
19. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
Scholl UI; Goh G; Stölting G; de Oliveira RC; Choi M; Overton JD; Fonseca AL; Korah R; Starker LF; Kunstman JW; Prasad ML; Hartung EA; Mauras N; Benson MR; Brady T; Shapiro JR; Loring E; Nelson-Williams C; Libutti SK; Mane S; Hellman P; Westin G; Åkerström G; Björklund P; Carling T; Fahlke C; Hidalgo P; Lifton RP
Nat Genet; 2013 Sep; 45(9):1050-4. PubMed ID: 23913001
[TBL] [Abstract][Full Text] [Related]
20. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
